ES2142842T3 - Alimentacion para personas infectadas por el virus de inmunodeficiencia humana. - Google Patents

Alimentacion para personas infectadas por el virus de inmunodeficiencia humana.

Info

Publication number
ES2142842T3
ES2142842T3 ES93114404T ES93114404T ES2142842T3 ES 2142842 T3 ES2142842 T3 ES 2142842T3 ES 93114404 T ES93114404 T ES 93114404T ES 93114404 T ES93114404 T ES 93114404T ES 2142842 T3 ES2142842 T3 ES 2142842T3
Authority
ES
Spain
Prior art keywords
human immunodeficiency
infected
nutritional product
person
immunodeficiency virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93114404T
Other languages
English (en)
Inventor
Frederick Oliver Cope
Normanella Torres Dewille
Ernest William Richards
Bonnie Chandler Abbruzzese
Michael Allen Chandler
Gregory Allan Snowden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/069,264 external-priority patent/US5330972A/en
Priority claimed from US08/069,066 external-priority patent/US5480872A/en
Priority claimed from US08/069,269 external-priority patent/US5403826A/en
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2142842T3 publication Critical patent/ES2142842T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Abstract

UN PRODUCTO NUTRICIONAL ENTERAL PARA PERSONAS INFECTADAS CON EL VIRUS DE INMUNODEFICIENCIA HUMANA CONTIENE UN HIDROLISATE DE PROTEINA DE SOJA QUE TIENE UNA PARTICION DE PESO MOLECULAR, SEGUN SE DETERMINE MEDIANTE LA CROMATOGRAFIA POR EXCLUSION DE TAMAÑO, EN DONDE DEL 3060% DE LAS PARTICULAS TIENEN UN PESO MOLECULAR EN EL RANGO DE 15005000 DALTONS. EL PRODUCTO NUTRICIONAL TAMBIEN CONTIENE UNA FUENTE DE PROTEINA SANA. EL PRODUCTO NUTRICIONAL TIENE UNA RELACION, EN PESO, DE N-6 A N-3 DE ACIDOS GRASOS DE SOBRE 1.3:1 HASTA 2.5:1. EL SOPORTE NUTRICIONAL ENTERAL DE UNA PERSONA INFECTADA CON EL VIRUS DE INMUNODEFICIENCIA PUEDE SUMINISTRARSE MEDIANTE LA INCLUSION DE ESTE PRODUCTO NUTRICIONAL ENTERAL EN LA DIETA DE LA PERSONA INFECTADA. APOPTOSIS DE CELULAS CD4 EN UNA PERSONA INFECTADA CON EL VIRUS DE INMUNODEFICIENCIA PUEDE SER IMPEDIDA MEDIANTE LA ALIMENTACION DE LA PERSONA INFECTADA CON ESTE PRODUCTO NUTRICIONAL ENTERAL.
ES93114404T 1993-05-28 1993-09-08 Alimentacion para personas infectadas por el virus de inmunodeficiencia humana. Expired - Lifetime ES2142842T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/069,264 US5330972A (en) 1993-05-28 1993-05-28 Method of impeding apoptosis of CD4 cells in persons infected with human immunodeficiency virus
US08/069,066 US5480872A (en) 1993-05-28 1993-05-28 Method of providing enternal nutritional support to persons infected with human immunodeficiency virus
US08/069,269 US5403826A (en) 1993-05-28 1993-05-28 Nutritional product for persons infected with human immunodeficiency virus

Publications (1)

Publication Number Publication Date
ES2142842T3 true ES2142842T3 (es) 2000-05-01

Family

ID=27371464

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93114404T Expired - Lifetime ES2142842T3 (es) 1993-05-28 1993-09-08 Alimentacion para personas infectadas por el virus de inmunodeficiencia humana.

Country Status (15)

Country Link
EP (1) EP0626177B1 (es)
JP (1) JPH089545B2 (es)
KR (1) KR970005330B1 (es)
AT (1) ATE187076T1 (es)
AU (1) AU651284B1 (es)
CA (1) CA2105790C (es)
DE (1) DE69327159T2 (es)
DK (1) DK0626177T3 (es)
ES (1) ES2142842T3 (es)
GR (1) GR3032748T3 (es)
IL (1) IL106975A (es)
NZ (1) NZ248603A (es)
PH (1) PH30682A (es)
PT (1) PT626177E (es)
TW (1) TW492867B (es)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007063143A1 (es) * 2005-11-30 2007-06-07 Katry Inversiones, S.L. Mezcla de lipidos y su utilización para preparar un producto destinado a la adminitracion enteral u oral
WO2007063141A1 (es) * 2005-11-30 2007-06-07 Katry Inversiones, S.L. Producto alimenticio para la nutrición por vía enteral u oral
WO2007063142A1 (es) * 2005-11-30 2007-06-07 Katry Inversiones, S.L. Mezcla de proteínas y su utilización para preparar un producto destinado a la alimentación oral o enteral

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ248605A (en) * 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat
US5759548A (en) 1993-11-30 1998-06-02 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
DE19528461A1 (de) * 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
CA2229435A1 (en) * 1995-09-14 1997-03-20 Lxr Biotechnology Inc. Compositions with anti-apoptotic activity, containing a mixture of phospholipids
US5681600A (en) * 1995-12-18 1997-10-28 Abbott Laboratories Stabilization of liquid nutritional products and method of making
US5981587A (en) * 1996-07-31 1999-11-09 Abbott Laboratories Water-miscible esters of mono- and diglycerides having antimicrobial activity and their use in inhibiting infection
US5908862A (en) * 1996-07-31 1999-06-01 Abbot Laboratories Water-miscible esters of mono--and diglycerides having antibacterial activity and their use in inhibiting infection
US5866606A (en) * 1996-07-31 1999-02-02 Abbott Laboratories Nutritional formulations containing water-miscible lipid derivatives as anti-microbial agents
US5958974A (en) * 1996-07-31 1999-09-28 Abbott Laboratories Nutritional formulations containing water-miscible lipid derivatives as antibacterial agents
DK0918742T3 (da) * 1996-07-31 2002-12-09 Abbott Lab Med vand blandbare estere af monoglycerider, som har anti-mikrobiel aktivitet
US6495532B1 (en) 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US6200950B1 (en) * 1998-02-18 2001-03-13 Nestec S.A. Calorically dense nutritional composition
US6949528B1 (en) 1998-03-18 2005-09-27 Goddard John G Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
US6194379B1 (en) 1998-05-01 2001-02-27 Abbott Laboratories Elemental enteral formula
US6413556B1 (en) 1999-01-08 2002-07-02 Sky High, Llc Aqueous anti-apoptotic compositions
EP1236405B1 (en) * 2001-03-01 2006-06-21 Societe Des Produits Nestle S.A. Hypoallergenic formulae inducing oral tolerance to soy proteins
EP1281325A1 (en) * 2001-07-30 2003-02-05 Societe Des Produits Nestle S.A. Nutritional composition preventing bacterial overgrowth
JP4554149B2 (ja) * 2002-11-28 2010-09-29 雅美 森山 レトロウイルス感染症治療薬
RU2006111443A (ru) * 2003-09-10 2006-09-10 Юнилевер Н.В. (Nl) Пищевая композиция
EP1723951A1 (en) † 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
US20080015166A1 (en) * 2004-06-22 2008-01-17 N.V. Nutricia Barrier Integrity in Hiv Patients
DE102004040452A1 (de) * 2004-08-20 2006-02-23 N.V. Nutricia Peptidgemisch
JP5098198B2 (ja) * 2005-03-28 2012-12-12 大正製薬株式会社 銅化合物配合組成物
AP2008004567A0 (en) * 2006-01-31 2008-08-31 Parsroos Co Use of a combination of ethanolic Rosa SP., UrticaDiaca and tanacetum vulgare extracts, further com prising selenium and aure and having been exposed to a pulsed electromagnetic field, for the preparation of a medicament for immunostimulation and/or tratment of HIV infections
JP2007246509A (ja) * 2006-02-16 2007-09-27 Taisho Pharmaceut Co Ltd 銅化合物配合経口用組成物
JP5181486B2 (ja) * 2006-02-16 2013-04-10 大正製薬株式会社 亜鉛化合物配合経口用組成物
US9259024B2 (en) * 2008-10-10 2016-02-16 Solae Llc High caloric enteral formulations
CN107072276A (zh) * 2014-09-01 2017-08-18 马修·乔利·瓦达科姆里 一种优化的营养食品

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0189161B1 (en) * 1985-01-29 1991-07-24 Abbott Laboratories Enteral nutritional hypoallergenic formula
SE8601828D0 (sv) * 1986-04-21 1986-04-21 Novo Industri As Enteral diet product and agent for production thereof
AU596880B2 (en) * 1986-09-17 1990-05-17 Clintec Nutrition Company Liquid nutritional compositions
DK3991D0 (da) * 1991-01-10 1991-01-10 Novo Nordisk As Fremgangsmaade til fremstilling af et proteinhydrolysat
NZ248605A (en) * 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007063143A1 (es) * 2005-11-30 2007-06-07 Katry Inversiones, S.L. Mezcla de lipidos y su utilización para preparar un producto destinado a la adminitracion enteral u oral
WO2007063141A1 (es) * 2005-11-30 2007-06-07 Katry Inversiones, S.L. Producto alimenticio para la nutrición por vía enteral u oral
WO2007063142A1 (es) * 2005-11-30 2007-06-07 Katry Inversiones, S.L. Mezcla de proteínas y su utilización para preparar un producto destinado a la alimentación oral o enteral

Also Published As

Publication number Publication date
ATE187076T1 (de) 1999-12-15
NZ248603A (en) 1994-12-22
JPH06340545A (ja) 1994-12-13
PT626177E (pt) 2000-05-31
EP0626177A2 (en) 1994-11-30
IL106975A (en) 1996-01-19
IL106975A0 (en) 1993-12-28
CA2105790C (en) 1998-07-28
EP0626177B1 (en) 1999-12-01
DE69327159T2 (de) 2000-07-13
GR3032748T3 (en) 2000-06-30
DK0626177T3 (da) 2000-05-08
KR970005330B1 (ko) 1997-04-15
AU651284B1 (en) 1994-07-14
CA2105790A1 (en) 1994-11-29
PH30682A (en) 1997-09-16
JPH089545B2 (ja) 1996-01-31
DE69327159D1 (de) 2000-01-05
TW492867B (en) 2002-07-01
EP0626177A3 (en) 1995-02-22

Similar Documents

Publication Publication Date Title
ES2142842T3 (es) Alimentacion para personas infectadas por el virus de inmunodeficiencia humana.
ES2062741T3 (es) Formulaciones nutritivas de alta acidez.
DE69205192T2 (de) Gluciden enthaltend Zusammenstellungen zur Diät und Therapie und ihre Verwendungen.
ATE88631T1 (de) Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen.
DK0626176T3 (da) Næringsmiddel til personer, som undergår stråleterapi eller kemoterapi
ES2044796T1 (es) Material alimenticio compuesto para economizar la secrecion de insulina.
ATE178615T1 (de) Verwendung eines dekapeptids mit benzodiazepinischer wirkung zur herstellung von arzneimitteln und diätzusätzen
WO1988003150A3 (fr) Preparations aminoacides contenant des peptides de n,n'-bis-l-aminoacide-l-cystine et destinees a l'administration orale et parenterale
DK657789D0 (da) I naeringsmaessig henseende komplet, enteralt, diaetetisk produkt
BR0110533A (pt) Método para a intensificação da resposta imunológica em um cão; método para aumento da blastogênese de linfócitos em um cão; e uso de alho
ITRM920205A0 (it) Prodotto dietetico energetico per soggetti sottoposti ad affaticamentofisico.
TH13900EX (th) ผลไม้ประดิษฐ์
TH13907EX (th) ผลไม้ประดิษฐ์
TH13901EX (th) ผลไม้ประดิษฐ์
TH13910EX (th) ผลไม้ประดิษฐ์
TH13897EX (th) ผลไม้ประดิษฐ์
TH13911EX (th) ผลไม้ประดิษฐ์
TH13908EX (th) ผลไม้ประดิษฐ์
TH13903EX (th) ผลไม้ประดิษฐ์
TH13906EX (th) ผลไม้ประดิษฐ์
TH13894EX (th) ผลไม้ประดิษฐ์
TH13905EX (th) ผลไม้ประดิษฐ์
TH13904EX (th) ผลไม้ประดิษฐ์
TH13902EX (th) ผลไม้ประดิษฐ์
TH13909EX (th) ผลไม้ประดิษฐ์

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 626177

Country of ref document: ES